AU2750588A - Anthelmintic compositions - Google Patents

Anthelmintic compositions

Info

Publication number
AU2750588A
AU2750588A AU27505/88A AU2750588A AU2750588A AU 2750588 A AU2750588 A AU 2750588A AU 27505/88 A AU27505/88 A AU 27505/88A AU 2750588 A AU2750588 A AU 2750588A AU 2750588 A AU2750588 A AU 2750588A
Authority
AU
Australia
Prior art keywords
anthelmintic compositions
anthelmintic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27505/88A
Inventor
Colin Manson Harvey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ancare Distributors Ltd
Original Assignee
Ancare Distributors Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ancare Distributors Ltd filed Critical Ancare Distributors Ltd
Publication of AU2750588A publication Critical patent/AU2750588A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
AU27505/88A 1988-01-15 1988-12-23 Anthelmintic compositions Abandoned AU2750588A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ223200 1988-01-15
NZ22320088A NZ223200A (en) 1988-01-15 1988-01-15 Anthelmintic compositions containing 2',5-dicloro-4'-nitrosalicylanilide and non aqueous carrier

Publications (1)

Publication Number Publication Date
AU2750588A true AU2750588A (en) 1989-07-20

Family

ID=19922334

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27505/88A Abandoned AU2750588A (en) 1988-01-15 1988-12-23 Anthelmintic compositions

Country Status (3)

Country Link
AU (1) AU2750588A (en)
GB (1) GB2213722A (en)
NZ (1) NZ223200A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023590A1 (en) * 1994-03-03 1995-09-08 Bomac Laboratories Limited Anthelmintic preparation
WO1997011709A1 (en) * 1995-09-25 1997-04-03 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
WO1999051201A1 (en) * 1998-04-03 1999-10-14 Ashmont Holdings Limited Sustained release formulation
CN103583513A (en) * 2013-12-03 2014-02-19 四川省化学工业研究设计院 Suspending agent of chlorosalicylamide as snail control drug and preparation method thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487973B1 (en) * 1990-11-26 1996-03-27 Bayer Corporation Topical lotion containing Niclosamide
WO1998018463A1 (en) * 1996-10-25 1998-05-07 Chemvet (Nz) Limited Anthelmintic formulation
FR2755824B1 (en) * 1996-11-19 1999-01-08 Virbac Sa GALENIC FORMULATION OF BENZIMIDAZOLES FOR TOPICAL USE, PREPARATION METHOD AND USES THEREOF
DE19654079A1 (en) 1996-12-23 1998-06-25 Bayer Ag Endo-ecto-parasiticidal agents
AU8108698A (en) * 1997-06-11 1998-12-30 Bayer Aktiengesellschaft Anthelmintic compositions
GB2386066A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
GB2386067A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species
CN1985813B (en) * 2006-12-07 2010-10-06 江苏省血吸虫病防治研究所 Metronidazole ethanolamine spray as blood flukedisease preventing and treating medicine for farm cattle and its preparing method
BR112018004069A2 (en) 2015-09-01 2021-07-13 First Wave Bio, Inc. solid pharmaceutical composition, enema preparation comprising niclosamide, enema formulation, use of niclosamide and kit
RU2635514C1 (en) * 2016-10-13 2017-11-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита (ООО "НВЦ Агроветзащита") Drug for animal helminthosis treatment
US20210114973A1 (en) * 2019-10-18 2021-04-22 First Wave Bio, Inc. Pharmaceutical formulations
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557615C2 (en) * 1975-12-20 1985-08-14 Bayer Ag, 5090 Leverkusen New niclosamide suspension formulations
PT84842B (en) * 1986-05-08 1990-02-08 R & C Produts Pty Limited PROCESS FOR THE PREPARATION OF COMPOSITIONS CONTAINING IPECACUANHA WHICH REPELL ANIMALS

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023590A1 (en) * 1994-03-03 1995-09-08 Bomac Laboratories Limited Anthelmintic preparation
US5925374A (en) * 1994-03-03 1999-07-20 Bomac Laboratories Limited Anthelmintic preparation
WO1997011709A1 (en) * 1995-09-25 1997-04-03 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
AU713580B2 (en) * 1995-09-25 1999-12-02 Merial Ltd Anthelmintic macrocyclic lactone compositions
US6013636A (en) * 1995-09-25 2000-01-11 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
WO1999051201A1 (en) * 1998-04-03 1999-10-14 Ashmont Holdings Limited Sustained release formulation
CN103583513A (en) * 2013-12-03 2014-02-19 四川省化学工业研究设计院 Suspending agent of chlorosalicylamide as snail control drug and preparation method thereof

Also Published As

Publication number Publication date
GB8900576D0 (en) 1989-03-08
NZ223200A (en) 1989-01-06
GB2213722A (en) 1989-08-23

Similar Documents

Publication Publication Date Title
AU4290789A (en) Oral compositions
AU4148989A (en) Pharmaceutical compositions
AU3481089A (en) Oral compositions
AU1714088A (en) Cimetidine compositions
AU3588089A (en) Oral compositions
AU3674489A (en) Pharmaceutical compositions
AU1714188A (en) Cimetidine compositions
AU3634589A (en) Improved primer compositions
AU3480889A (en) Oral compositions
AU3310789A (en) Macrolide compositions
AU626930B2 (en) Immunostimulatory composition
AU2891589A (en) Polymeric compositions
AU3015189A (en) Cleansing compositions
AU2750588A (en) Anthelmintic compositions
AU596718B2 (en) Compositions for external application
AU3946689A (en) Oral compositions
AU4447189A (en) Oral compositions
AU7336487A (en) Pharmaceutical compositions
AU622467B2 (en) Cement compositions
AU1925488A (en) Pharmaceutical compositions
AU607451B2 (en) Pharmaceutical compositions
AU4082989A (en) Polyisocyanate compositions
AU7939487A (en) Pharmaceutical compositions
AU3027389A (en) Compositions
AU2032488A (en) Storage-stable hydrocurable oxazolidine-isocyanate compositions